Large-scale testing (Phase 3)Active Not RecruitingNCT05627648What this trial is testingPhase 3 Study of KP-100LI in Subjects With Vocal Fold ScarWho this might be right forVocal Fold Scar Kringle Pharma, Inc. 62
Large-scale testing (Phase 3)Study completedNCT00917384What this trial is testingStudy of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and AdenocarcinomaWho this might be right forGastric CancerAdenocarcinoma Eli Lilly and Company 355
Testing effectiveness (Phase 2)Study completedNCT00031148What this trial is testingKeratinocyte Growth Factor to Prevent Acute GVHDWho this might be right forGraft-vs-Host Disease FDA Office of Orphan Products Development 72
Testing effectiveness (Phase 2)Study completedNCT01096784What this trial is testingIGF-1/IGFBP3 Prevention of Retinopathy of PrematurityWho this might be right forRetinopathy of Prematurity (ROP) Shire 121
Not applicableLooking for participantsNCT03662178What this trial is testingInvestigating the Structured Use of Ultrasound Scanning for Fetal GrowthWho this might be right forStillbirthFetal DeathFetal Growth Retardation+4 more Oxford University Hospitals NHS Trust 56,000
Not applicableUnknownNCT05484050What this trial is testingVEGF in Iris Tissue in Primary Congenital GlaucomaWho this might be right forIris Hassan Lotfy Fahmy 30
Testing effectiveness (Phase 2)Study completedNCT02187991What this trial is testingStudy to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast CancerWho this might be right forBreast CancerBreast CarcinomaBreast Tumors+1 more US Oncology Research 169
Testing effectiveness (Phase 2)Looking for participantsNCT06920043What this trial is testingEfimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASHWho this might be right forMetabolic Dysfunction-Associated SteatohepatitisNon-alcoholic Fatty Liver Disease GlaxoSmithKline 42
Testing effectiveness (Phase 2)Study completedNCT01271725What this trial is testingLUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment FailuresWho this might be right forBreast Neoplasms Boehringer Ingelheim 74
Testing effectiveness (Phase 2)Study completedNCT00615758What this trial is testingErlotinib as 1st Line Treatment in NSCLC Stage IIIB/IVWho this might be right forNon Small Cell Lung Cancer Hellenic Oncology Research Group 50
Testing effectiveness (Phase 2)Ended earlyNCT04066790What this trial is testingPyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast CancerWho this might be right forBreast Cancer Shanghai Jiao Tong University School of Medicine 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06635447What this trial is testingCapivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese PatientsWho this might be right forBreast Cancer AstraZeneca 293
Testing effectiveness (Phase 2)Ended earlyNCT04489940What this trial is testingBintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast CancerWho this might be right forTriple Negative Breast Neoplasms EMD Serono Research & Development Institute, Inc. 11
Testing effectiveness (Phase 2)Ended earlyNCT03827850What this trial is testingFGFR Inhibitor in FGFR Dysregulated CancerWho this might be right forLung CancerNSCLCPulmonary Neoplasm+2 more Lung Cancer Group Cologne 22
Early research (Phase 1)Active Not RecruitingNCT04167540What this trial is testingGDNF Gene Therapy for Parkinson's DiseaseWho this might be right forParkinson's Disease Brain Neurotherapy Bio, Inc. 11
Testing effectiveness (Phase 2)UnknownNCT03424759What this trial is testingUncommon EGFR AZD9291Who this might be right forNon Small Cell Lung Cancer Samsung Medical Center 37
Early research (Phase 1)Study completedNCT01928459What this trial is testingPhase 1b Trial of BGJ398/BYL719 in Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Solid Tumors Novartis Pharmaceuticals 62
Testing effectiveness (Phase 2)Study completedNCT00258960What this trial is testingCaelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast CancerWho this might be right forBreast Cancer Spanish Breast Cancer Research Group 49
Not applicableStudy completedNCT01781117What this trial is testingPrognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic HyperplasiaWho this might be right forBenign Prostatic Hypertrophy With Outflow ObstructionOveractive Detrusor KYU-SUNG LEE 184
Early research (Phase 1)Study completedNCT00000180What this trial is testingAIT-082 Phase 1B StudyWho this might be right forMemory Disorders National Institute on Aging (NIA)